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ORAL PRESENTATION
ABLATION TECHNOLOGY
OP 16-1 Feasibility and clinical usefulness of high resolution sound map with cross plane method for AF ablation
Yeong-Hwa CHUN (Eiwa Zen) (Japan)
i1
OP 16-2 Robotic navigation for catheter ablation of atrial fibrillation – is there a learning curve?
Fahd CHAHADI (Australia)
i1
OP 16-3 Effect of atrial fibrillation on catheter-tissue contact during antral pulmonary vein isolation in 
humans: lower contact force at the left anterior pulmonary vein in atrial fibrillation compared to 
sinus or paced rhythm
Saurabh KUMAR (Australia)
i1
OP 16-4 First human validation of a new epicardial access needle with a real time pressure monitoring to 
facilitate epicardial access
Luigi DI BIASE (United States of America)
i1
OP 16-5 Endoscopic ablation by unilateral approach (left chest) for lone atrial fibrillation: a single center 
experience in 100 consecutive patients
Ju MEI (China)
ix
OP 16-6 Exploring the relationship between contact force and clinical outcomes between human and robot-
assisted AF ablation: early results of MAST-AF
Gavin S CHU (United Kingdom)
i2
AFL ABLATION
OP 14-1 Effect of respiration on catheter movement and stability during cavotricuspid isthmus ablation for 
atrial flutter
Saurabh KUMAR (Australia)
i3
OP 14-2 Electroanatomic characterization and ablation outcome of nonlesion related left atrial 
macroreentrant tachycardiain patients without obvious structural heart disease
Jinlin ZHANG (China)
i3
OP 14-3 Characteristics of atrial flutter in children and young adults
Yuriko ABE (Japan)
i3
OP 14-4 Predictors of development of atrial fibrillation on long-term follow up in patients with macro re-
entrant tachycardias: insights from an atrial flutter ablation registry
Shunmuga SUNDARAM (India)
i3
OP 14-5 Long term outcome of atrial flutter ablation in surgically corrected ASD patients
Zulkeflee MUHAMMAD (Malaysia)
i4
OP 14-6 Pouch depth is the sole factor affecting the radiofrequency duration and energy for right atrial 
cavotricuspid isthmus catheter ablation
Kazuto KUJIRA (Japan)
i4
ALTERNATIVE SITE PACING
OP 22-1 Getting RV lead at thinner part of interventricular septum tends to shorten paced QRS duration with 
less dyssynchrony
Dmytro VOLKOV (Ukraine)
i5
OP 22-2 Is right ventricular outflow tract (RVOT) septal pacing better than right ventricular apical (RVA) septal 
pacing with regard to long term left ventricular function and mechanical synchrony?
Gaurav GANESHWALA (India)
i5
OP 22-3 Paced QRS duration as a predictor for clinical heart-failure events during right ventricular apical 
pacing in patients with idiopathic complete atrioventricular block
Shaojie CHEN (China)
i5
OP 22-4 Acute haemodynamic and hormonal effects of right ventricular apical pacing compared to right 
ventricular outflow tract pacing in non-bradycardic patients with normal ventricular function
Paul GOULD (Australia)
i5
OP 22-5 Left atrial responses to acute right ventricular apical pacing in patients with sick sinus syndrome
Kyoung Im CHO (South Korea)
i6
OP 22-6 Long-term effect of right ventricular outflow tract versus apical pacing on cardiac function and 
synchrony
Yu JUN (China)
i6
ANTICOAGULATION MANAGEMENT
OP 10-1 Does the peri-procedural anticoagulation management for AF affect the prevalence of silent 
thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging (DMRI) in 
patients undergoing atrial fibrillation ablation with open irrigated radiofrequency energy?
Luigi DI BIASE (United States of America)
i7
OP 10-2 Safety of right-sided atrial flutter ablation performed under novel oral anticoagulants
Jean-Francois SARRAZIN (Canada)
i7
OP 10-3 Pulmunary vein isolation in patients with atrial fibrillation with peri-procedural dabigatran
Amitabh YADUVANSHI (India)
i7
OP 10-5 Cost-effectiveness analysis of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention 
in atrial fibrillation: a population-based study in taiwan
Chieh-Yu LIU (Taiwan)
i7
OP 10-6 Dabigatran use in atrial fibrillation patients at high risk of stroke: a single centre experience
Lok Bin YAP (Malaysia)
i8
ATRIAL FIBRILLATION (ABLATION) I
OP 04-1 Ganglionated plexi ablation directed by high-frequency stimulation and complex fractionated atrial 
electrograms for paroxysmal atrial fibrillation
Artem STRELNIKOV (Russia)
i9
OP 04-2 Ganglionated plexi ablation combined with pulmonary vein isolation improves outcome of catheter 
ablation in patients with longstanding persistent atrial fibrillation: a prospective randomized 
comparison
Sevda BAYRAMOVA (Russia)
i9
OP 04-3 Fractionated atrial potential at anatomical ganglionated plexi sites in atrial fibrillation – investigation 
by electrical anatomical mapping system
Daisuke ISHIGAKI (Japan)
i9
OP 04-4 Surgical ablation by unilateral approach (left chest) for lone atrial fibrillation: a single center 
experience in 100 consecutive patients
Ju MEI (China)
i9
OP 04-5 Efficacy of catheter ablation of atrial fibrillation using robotic navigation
Fahd CHAHADI (Australia)
i10
OP 04-6 Surrogates markers have limited ability for predicting pre-ablation contact force and lesion efficacy 
during catheter ablation of atrial arrhythmias in humans
Saurabh KUMAR (Australia)
i10
ATRIAL FIBRILLATION (ABLATION) II
OP 06-1 Directed ablation of regions of high shannon entropy as potential marker of AF rotors: initial clinical 
experience
Anand GANESAN (Australia)
i11
OP 06-2 Cryoablation of pulmonary veins for paroxysmal atrial fibrillation: comparison of acute and mid-term 
outcome between first and second generation balloon
Massimo MOLTRASIO (Italy)
i11
OP 06-3 Contact force values during ablation for pulmonary vein isolation: analysis according to anatomy 
and operators
Roberto DE PONTI (Italy)
i11
OP 06-4 Clinical impact of anatomical variation of vein of marshall (VOM) on creating bi-directional 
conduction block at mitral isthmus after ethanol infusion into VOM
Naohiko KAWAGUCHI (Japan)
i11
OP 06-5 Marked variation in catheter-tissue contact force during cavotricuspid isthmus ablation using 
traditional markers of good contact
Saurabh KUMAR (Australia)
i11
OP 06-6 Remote magnetic navigation for mapping and ablation of atrial fibrillation
Wee Siong TEO (Singapore)
i12
ATRIAL FIBRILLATION (ABLATION) III
OP 08-1 Sequential hybrid approach: results of novel approach in the treatment of long-standing persistent 
atrial fibrillation
Alan BULAVA (Czech Republic)
i13
OP 08-2 Clinical success of radiofrequency catheter ablation of atrial fibrillation using two different ablation 
catheter: a comparison between a conventional irrigated tip ablation catheter vs. contact therapy 
cool path duo ablation catheter with complex impeda
Karlheinz SEIDL (Germany)
i13
OP 08-3 Conduction gaps after the first round of circumferential pulmonary vein isolation tend to reconnect 
in the second procedure even after additional ablation
Kojiro TANIMOTO (Japan)
i13
OP 08-4 Esophageal temperature monitoring during pulmonary vein isolation by electrogram-guided point 
ablation
Shin-ichi TANIGAWA (Japan)
i13
OP 08-5 Mapping of undistinguishable focal atrial tachycardia post extensive ablation in the atrium: tricks and tips
Weizhu JU (China)
i14
BASIC AND TRANSLATIONAL SCIENCE I
OP 12-1 High resolution unipolar mapping with a new multi electrode mapping system predicts infarct scar 
thickness in a canine infarct model
Anees THAJUDEEN (United States of America)
i15
OP 12-2 Left stellate ganglion block suppress Ca2+/Calmodulin-dependent protein kinase ii activation and 
arrhythmia in autoimmune myocarditis model
Hyelim PARK (South Korea)
i15
OP 12-3 Expression and regulation of the small-conductance calcium-activated potassium channels in 
diabetic mouse atria
Fu YI (China)
i15
OP 12-4 The relationship among complex fractionated electrograms, wavebreak, phase singularity, and local 
dominant frequency in fibrillation wave-dynamics: a modeling comparison study
Minki HWANG (South Korea)
i15
OP 12-5 Feasibility, efficacy and safety of percutaneous retrieval of a leadless cardiac pacemaker in an IN VIVO 
ovine model
Johannes SPERZEL (Germany)
i16
OP 12-6 Renal sympathetic denervation attenuates the inducibility of ventricular arrhythmia and 
electrophysiological substrate in dogs with pacing-induced heart failure
Qingyan ZHAO (China)
i16
BASIC AND TRANSLATIONAL SCIENCE II
OP 20-2 TRPC3 channel-dependent regulation of fibroblast proliferation/differentiation in atrial fibrillation
Masahide HARADA (Canada)
i17
OP 20-3 Receptor for advanced glycation endproducts suppressed arrhythmia by reducing infarct size and 
apoptosis in myocardial infarction
Hyelim PARK (South Korea)
i17
OP 20-4 Blockade of NaV1.8 channels in ganglionated plexi influences cardiac conduction and atrial 
fibrillation inducibility
Baozhen QI (China)
i17
OP 20-5 An innovative mathematical model with quantum number for rhythm phenomenon and its 
computer simulation
Mingliang YANG (China)
i17
OP 20-6 The role of gap junction in atrial fibrillation caused by atrial stretch
Norihiro UEDA (Japan)
i18
Apamin induces early afterdepolarizations and triggered activity from failing rabbit ventricular 
myocardium with secondary rise of intracellular calcium
Po-Cheng CHANG (Taiwan)
i18
BIOMARKERS
OP 02-1 Predictive potency of big endothelin-1 on response and long-term survival following cardiac 
resynchronization therapy
Xinwei YANG (China)
i19
OP 02-2 Decreased endothelial nitric oxide production is more closely related with framigham risk than 
CHA2DS2-VASc scores in paroxysmal atrial fibrillation
Bonpei TAKASE (Japan)
i19
OP 02-3 Predictive value of plasma N-terminal pro brain natriuretic peptide levels in left atrial spontaneous 
echo contrast in patients with atrial fibrillation
Kyoung Im CHO (South Korea)
i19
OP 02-4 Plasma level of galectin-3 has inverse relationship with transforming growth factor-b and predictive 
value for clinical recurrence of atrial fibrillation after catheter ablation
Jae Hyung PARK (South Korea)
i19
OP 02-5 QT dispersion: a marker of coronary artery disease and microvascular dysfunction
Betty RAMAN (Australia)
i20
OP 02-6 The relationship between the secretion of B-type natriuretic peptide and the effects of several factors 
in patients with atrial fibrillation
Yukiko HAYAMA (Japan)
i20
CARDIAC RESYNCHRONIZATION THERAPY I
OP 01-1 Electrogram characteristics of quadripolar leads - implications for multipoint pacing
David O'DONNELL (Australia)
i21
OP 01-2 Cardiac resynchronization therapy (CRT) - does multiple pacing configurations with the quadripolar 
LV lead overcome suboptimal lead positioning
Veeresh PATIL (India)
i21
OP 01-3 Impact of steroid eluting on performance of multiple electrode left ventricular cardiac vein leads in CRT
Ping YANG (United States of America)
i21
OP 01-4 Is the most delayed site the best site for LV lead pacing? insights from optimal LV lead positions
Darragh FLANNERY (Australia)
i21
OP 01-5 Is left sided single lead DDD pacing feasible?
Vinayakrishnan RAJAN (Netherlands)
i22
OP 01-6 Targeted lead implantation using a novel left ventricular active fixation lead
Azlan HUSSIN (Malaysia)
i22
CARDIAC RESYNCHRONIZATION THERAPY II
OP 03-1 Influence of intra-atrial block on the effect of cardiac resynchronization therapy
Qi SUN (China)
i23
OP 03-2 Effects of atrioventricular conduction delay on the outcome of cardiac resynchronization therapy
Ying-Hsiang LEE (Taiwan)
i23
OP 03-3 Cardiac resynchronization therapy (CRT) response and clinical outcomes in NYHA class IV patients: a 
real world experience
Avinash VERMA (India)
i23
OP 03-4 Effect of cardiac resynchronization therapy in heart failure patients with right branch bundle block 
after ultrasound assessment by tissue doppler imaging
Yi FU (China)
i23
OP 03-5 Characterization of mechanical and electrical activation patterns in patients with systolic dysfunction 
evaluated using a novel non-fluoroscopic 4D navigation system
Gerhard HINDRICKS (United States of America)
i24
OP 03-6 Comparison between CRT-D and CRT-P of the elderly patients in saitama medical school international 
medical center
Yoshifumi IKEDA (Japan)
i24
CARDIAC RESYNCHRONIZATION THERAPY III
OP 05-1 Simple protocol of follow-up patients on CRT and its results
Yura MAREEV (Russia)
i25
OP 05-2 A cost analysis of cardiac resynchronization therapy in patients with atrioventricular nodal disease 
and reduced ejection fraction
Bhupesh PATHIK (Australia)
i25
OP 05-3 Real world assessment of left ventricular lead implant success and complication rates: results from 
asia-pacific region in the attain success clinical trial
Balbir SINGH (India)
i25
OP 05-4 Effect of baseline QRS interval on cardiac resynchronization therapy (CRT) response: is wider always 
better?
Avinash VERMA (India)
i25
OP 05-5 CIED-infections: is the implantation of CIED in the cath lab safe?
Karlheinz SEIDL (Germany)
i26
OP 05-6 Risk factor associated device infection, pneumothorax and perforation of heart in 46,506 device 
implantations: a national population-based study
Tien-Hsing CHEN (Taiwan)
i26
GENETIC I
OP 09-1 Genome-wide association analysis identifies 3 common variants predisposing to brugada syndrome
Yuka MIZUSAWA (Netherlands)
i27
OP 09-2 SCN5A mutation is not a risk predictor of recurrent cardiac events for patients with symptomatic 
brugada syndrome: ten-year follow-up in a large chinese cohort (COBRA_ChiP registry)
Jyh-Ming Jimmy JUANG (Taiwan)
i27
OP 09-3 Variants in SCN5A promoter and regulatory regions associated with various arrhythmia phenotypes 
including sinus node dysfunction, conduction disease, atrial fibrillation, and idiopathic ventricular 
fibrillation
Nobue YAGIHARA (Japan)
i27
OP 09-4 The screening of catechol-o-methyl transferase gene (COMT) is a powerful tool to diagnose 
susceptibility for long QT-syndrome and for stratification for sudden cardiac death (SCD)
Dr Jerzy DYCZYNSKI (Australia)
i28
OP 09-5 Genetic background and management of long QT syndrome
Akiko KOMORI (Japan)
i28
OP 09-6 Angiotensin II type 1-receptor gene polymorphism, rs5182, is associated with clinical recurrence of 
atrial fibrillation after radiofrequency catheter ablation
Jaemin SHIM (South Korea)
i28
GENETIC II
OP 11-1 Cardiac genetic service in management of inherited arrhythmogenic diseases – pioneering 
experience of a regional referral centre
Ngai-Shing MOK (China)
i29
OP 11-2 Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and 
high yield in aborted cardiac arrest syndromes
Saurabh KUMAR (Australia)
i29
OP 11-3 Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset 
of heart failure
Yang LIU (China)
i29
OP 11-4 Low P wave amplitude in lead I is protective for clinical recurrence of atrial fibrillation after 
radiofrequency catheter ablation in patients with ZFHX3 rs2106261 GG genotype
Jae Hyung PARK (South Korea)
i29
OP 11-5 Prolonged PR interval has a predictive value for clinical recurrence of atrial fibrillation after 
radiofrequency catheter ablation in patients with chromosome 4q25 rs2200733 variants
Minjin CHOE (South Korea)
i30
OP 11-6 The early experiences of high efficiency mesh like irrigation tip ablation catheter (Coolflex) in atrial 
fibrillation ablations
Hui-Nam PAK (South Korea)
i30
PEDIATRIC & INHERITED ARRHYTHMIA
OP 07-1 Three-dimensional electroanatomical mapping for scar-related atrial tachycardias in patients with 
congenital heart disease
Xianhui ZHOU (China)
i31
OP 07-2 Multicentre long term follow-up of paediatric primary prevention ICD shocks
Hiroko ASAKAI (Australia)
i31
OP 07-3 A decade of RF ablation in children – a single centre experience
Mandar SHAH (India)
i31
OP 07-4 Single-centre experience in permanent pacemaker implantation in pediatric population with a five-
year follow-up
Niti CHADHA (India)
i31
OP 07-5 Mutation of desmoplakin gene and assessment of right ventricle function in patients with 
arrhythmogenic right ventricular cardiomyopathy
Qianhuan ZHANG (China)
i32
OP 07-6 Utility of modified moving average analysis of microvolt T-wave alternans to predict ventricular 
arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy
Xue SHELIANG (China)
i32
RVOT ABLATION
OP 21-2 Ablation of right ventricular outflow tract ventricular arrhythmias guided by non-contact mapping: 
techniques and long term clinical outcomes
Fengxiang ZHANG (China)
i33
OP 21-3 Relationship of the myocardial voltage map and successful ablation sites of idiopathic right 
ventricular outflow tract tachycardia
Jing WANG (China)
i33
OP 21-4 Second coupling interval to distinguish “malignant” from “benign” ventricular tachycardia originating 
from right ventricular outflow tract
Yoo Ri KIM (South Korea)
i33
OP 21-5 Ablation of idiopathic right ventricular outflow tract tachycardias under 3D mapping system: 
electrocardiographic and electrophysiological predictors of acute and short-term success
Dinesh CHOUDHARY (India)
i34
OP 21-6 Magnetic versus manual catheter navigation for mapping and ablation of right ventricular outflow 
tract ventricular arrhythmias: a randomized controlled study
Fengxiang ZHANG (China)
i34
SUDDEN CARDIAC DEATH
OP 13-1 Clinical outcomes among patients using a wearable external cardiac defibrillator vest
Robert HANSON (United States of America)
i35
OP 13-2 Surgical sympathectomy reduces ventricular tachycardia burden: a single center cohort study
Soumen DEVIDUTTA (India)
i35
OP 13-3 Early defibrillation without chest compressions improves outcome of out of hospital cardiac arrest
Alessandro CAPUCCI (Italy)
i35
OP 13-4 Chronic baroreflex activation reduces sympathetic tone in reduced-ejection fraction heart failure 
with maximally-tolerated beta-blockade: implications for arrhythmia susceptibility?
Edoardo GRONDA (Italy)
i35
OP 13-5 Pregnancy in severe hypertrophic cardiomyopathy: a multidisciplinary approach to care
Belinda GRAY (Australia)
i36
OP 13-6 Use of cardiac magnetic resonance imaging in predicting risk of idiopathic ventricular fibrillation
Michael WONG (Australia)
i36
SVT ABLATION
OP 18-1 Catheter ablation of epicardial accessory pathway associated with coronary sinus musculature: 
single-center clinical experience
Weizhu JU (China)
i37
OP 18-2 Electrophysiologic characteristics of supraventricular tachycardias with ebstein's anomaly
Wei WEI (China)
i37
OP 18-3 “Near-Zero” radiation exposure in catheter ablation of cardiac arrhythmias using electroanatomical 
mapping system
Man-Chun CHOI (Hong Kong)
i37
OP 18-4 Waiting times after catheter ablation for supraventricular tachycardias: do we really need them?
Simran SINHA (United Kingdom)
i37
OP 18-5 Left accessory pathway ablation-safety and superiority of antegrade vs retrograde approaches
Prakash V S (India)
i38
OP 18-6 Electrophysiologic testing and catheter ablation in young asymptomatic subjects with ventricular 
pre-excitation
Roberto DE PONTI (Italy)
i38
TACHYCARDIA THERAPY DEVICE (ICD)
OP 17-1 Evidence-based shock reduction programming in asia-pacific ICD patients: sub-group results from 
the shock-less trial
Vanita ARORA (India)
i39
OP 17-2 Incidence of antitachycardia therapy in patients undergoing AICD implantation for primary prevention
Amitabh YADUVANSHI (India)
i39
OP 17-3 Reuse of explanted ICDs for indigent patients
Soumen DEVIDUTTA (India)
i39
OP 17-4 Efficacy of antitachycardia pacing for terminating fast ventricular tachycardia in a japanese ICD 
population: primary results of the SATISFACTION study
Tetsuya WATANABE (Japan)
i39
OP 17-5 Clinical application of novel non-invasive parameter for potential arrhythmogenecity in patients 
with implantable cardioverter defibrillator: e-Reynolds number (eRe#)
Minki HWANG (South Korea)
i40
OP 17-6 How well do results from large randomized clinical trials evaluating device function diffuse into 
clinical practice? assessment of impact of the INTRINSIC compared to MADIT-RIT trials in a large 
cohort of implantable cardioverter defibrillator patients
Niraj VARMA (United States of America)
i40
VT ABLATION I
OP 24-1 High density mapping of ventricular scar- a comparison of ventricular tachycardia supporting 
channels with channels that do not support VT
Sachin NAYYAR (Australia)
i41
OP 24-2 Acute catheter ablation of electrical storm in patients with ischemic heart disease using a remote 
magnetic navigation system
Steen PEHRSON (Denmark)
i41
OP 24-3 Significance of abnormal potentials for guiding successful target of catheter ablation from the aortic 
sinus cusp ventricular arrhythmia
Xiaoyan LIU (China)
i41
OP 24-4 Radiofrequency catheter ablation of ventricular arrhythmias on the left papillary muscles
Wei WEI (China)
i41
OP 24-5 Posterior fascicle to myocardial conduction block during ILVT ablation: an electrophysiological 
marker of long-term success
Amitabh YADUVANSHI (India)
i42
OP 24-6 Electrophysiologic characteristics of induced ventricular tachycardia over multiple ablation procedures
Michifumi TOKUDA (Japan)
i42
VT ABLATION II
OP 25-2 Post infarction scar ventricular tachycardia (PISVT) ablation: superiority of substrate based mapping 
in sinus rhythm over entrainment mapping during ventricular tachycardia with reference to total 
procedural time and long term freedom from recurrence
Prakash V S (India)
i43
OP 25-3 Ablation of ventricular tachycardia during a “VT storm”
Amitabh YADUVANSHI (India)
i43
OP 25-4 Role of catheter ablation in drug refractory VT of granulomatous myocarditis
Mandar SHAH (India)
i43
OP 25-5 Efficacy and outcome of catheter ablation for sustained /nonsustained ventricular tachycardia - 
related electrical storm: a single center experience
Heng-Hsu LIN (Taiwan)
i43
OP 25-6 A novel strategy for mapping in sinus rhythm to localize ventricular tachycardia channels in ischemic 
cardiomyopathy
Sachin NAYYAR (Australia)
i44
CASE-BASED SESSION: ABLATION
OP 23-1 Catheter ablation of accessory pathway between the right atrial appendage and the right ventricle: 
a case report
Daljeet SAGGU (India)
i45
OP 23-2 Novel therapeutic approach for catheter ablation of incessant ventricular tachycardia associated with 
cardiac sarcoidosis: the usefulness of CARTO-SOUND® system
Shinya KOWASE (Japan)
i45
OP 23-3 Successful cryoablation of symptomatic nonpost-operative junctional ectopic tachycardia resistant 
to multidrug regimens: a case report
Ayhan KILIC (Turkey)
i45
OP 23-4 Ablation premature ventricular contractions in left coronary cusp with magnetic navigation catheter
Tian-You LING (China)
i45
OP 23-5 Radiofrequency ablation of a left posteriolateral accessory pathway in a patient with machenical 
mitral valve
Thuy TO HUNG (Vietnam)
i46
OP 23-6 Trans-subclavian vein approach plus trans-femoral vein approach improve the outcomes of catheter 
ablation of idiopathic ventricular arrhythmias originating from subtricuspid annulus
Li TENG (China)
i46
CASE-BASED SESSION: DEVICE
OP 19-1 Mitraclip for cardiac resynchronization therapy nonresponder with cardiogenic shock
Andrew NG (Hong Kong)
i47
OP 19-2 My difficult coronary sinus cannulation during biventricular pacemaker implantation
Manoj K ROHIT (India)
i47
OP 19-3 Case of implanting ICD by hybrid operation
Zhaoguang LIANG (China)
i47
OP 19-4 Renal artery embolism after biventricular pacemaker implantation: a case report and literature review
Xin ZHAO (China)
i48
OP 19-5 Two unusual cases of acute transient non-physiological over sensing in the ventricle with a DF4 lead
Paul GOULD (Australia)
i48
OP 19-6 Peroperative epicardial left ventricular (LV) lead placement in severe aortic valve disease and LV 
dysfunction undergoing valve replacement -report of three cases
S P ABHILASH (India)
i48
OP 19-7 Percutaneous mitral valve repair system (MitraClip) in CRT non-responders or CRT ineligible patients 
with severe functional mitral regurgitation
Ryan Ko (Hong Kong)
i48
CASE-BASED SESSION: GENETICS
OP 15-1 Molecular autopsy unmasked a novel mutation in CACNA1C underlying brugada syndrome in a 
young victim of sudden nocturnal death
Ngai-Shing MOK (China)
i49
OP 15-2 The profile of arrhythmia and its substrate during pregnancy in first relative andersen-tawil 
syndrome
Hidetoshi HATTORI (Japan)
i49
OP 15-3 Catecholaminergic polymorphic ventricular tachycardia in chinese children
TC YU (Hong Kong)
i49
OP 15-4 A case report and literature review of kearns-sayre syndrome
Xin ZHAO (China)
i49
OP 15-5 A family of long QT syndrome with the ECG characteristics provoked prominently in the response to 
brisk standing
Masamichi TANAKA (Japan)
i50
OP 15-6 Arrhythmogenic right ventricular dysplasia with total AV block manifestation
Aprilianasary UTAMI (Indonesia)
i50
BEST ABSTRACT AWARD SESSION
BA - 1 Role of the defibrillator vest as bridging therapy before ICD implantation
Johannes SPERZEL (Germany)
i51
BA - 2 A randomized controlled trial of a minimal or maximal ablation strategy to achieve pulmonary vein 
isolation for paroxysmal atrial fibrillation: medium term follow-up (the minimax trial)
Alex MCLELLAN (Australia)
i51
BA - 3 Electrophysiology of the PV-LA junction during acute stretch in humans: conduction slowing and 
complex fractionated electrograms
Tomos WALTERS (Australia)
i51
BA - 4 Promising outcome by high-dense ganglionated plexi ablation for patients with paroxysmal atrial 
fibrillation. two years follow-up study.
Norishige MORITA (Japan)
i51
BA - 5 Alpha B-crystallin prevents the arrhythmogenic effects of myocarditis by attenuating oxidative stress
Hyewon PARK (South Korea)
i52
BA - 6 Obesity and AF: reversal of obesity related pro-fibrotic factors expression, fibrosis regression and 
electro-structural reverse remodelling with weight reduction
Rajiv MAHAJAN (Australia)
i52
YOUNG INVESTIGATOR AWARD SESSION
YIA - 1 Characteristics and clinical correlates of late gadolinium enhancement by contrast-enhanced 
magnetic resonance imaging in indian patients with hypertrophic cardiomyopathy
Harikrishnan G (India)
i53
YIA - 2 Does termination of atrial fibrillation during ablation of long standing persistent atrial fibrillation 
predict the outcome at follow-up? results from a prospective randomized study
Luigi DI BIASE (United States of America)
i53
YIA - 3 A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial 
fibrillation: acute outcomes in a prospective multi-centre randomised controlled trial (the minimax study)
Alex MCLELLAN (Australia)
i53
YIA - 4 Usefulness of NOAC for perioperative period in atrial fibrillation ablation
Kenichi HIROSHIMA (Japan)
i53
YIA - 5 Diffuse ventricular fibrosis measured by T1 mapping on cardiac MRI predicts success of atrial 
fibrillation ablation
Alex MCLELLAN (Australia)
i54
YIA - 6 Causes of sudden cardiac death among young victims – a five-year review of autopsies done in Hong Kong
Ngai-Shing MOK (Hong Kong)
i54
CSPE BEST ABSTRACT AWARD SESSION
CSPE 01-1 Comparison of the retrograde and transseptal methaods for ablation of left accessory pathway by 
three-dimensional mapping system
Guoqiang ZHONG (China)
i55
CSPE 01-2 Effects of renal sympathetic denervation on the development of atrial fibrillation substrates in dogs 
with pacing-induced heart failure
Qingyan ZHAO (China)
i55
CSPE 01-3 A novel individualized substrate modification approach for the treatment of long-standing persistent 
atrial fibrillation (LPAF): preliminary results
Xin-hua WANG (China)
i55
CSPE 01-4 Catheter-based renal sympathetic denervation significantly inhibits atrial fibrillation induced by 
electrical stimulation of the left stellate ganglion and rapid atrial pacing
Qina ZHOU (China)
i55
CSPE 01-5 A common NOS1AP genetic polymorphism is associated with QTc interval and mortality in chronic 
heart failure in a chinese han case-control population
Xiaoyan LIU (China)
i56
CSPE 01-6 The effects of adenosine triphosphate on inducing atrial fibrillation after circumferential pulmonary vein 
isolation in paroxysmal atrial fibrillation: an insight into the mechanism and implication for ablation
Jinlin ZHANG (China)
i56
CSPE YOUNG INVESTIGATOR AWARD SESSION
CSPE 02-1 Invasive ablation for atrial fibrillation aided by sparse imaging of epicardial potentials
Liansheng WANG (China)
i57
CSPE 02-2 Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial 
fibrillation patients with rheumatic mitral valve disease
Peide ZHANG (China)
i57
CSPE 02-3 Influence of intra-atrial block on the incidence of new onset atrial fibrillation after cardiac 
resynchronization therapy
Qi SUN (China)
i57
CSPE 02-4 A novel SCN5A gene mutation in chinese patients of atrial fibrillation
Zhen-yan XU (China)
i57
CSPE 02-5 Catheter ablation of atrial flutter originated from a giant left atrium
Yu ZHANG (China)
i58
CSPE 02-6 Feasible and effective predictor of cardiac resynchronization therapy: paced left ventricular QRS width
Chunsheng AN (China)
i58
